Flamel Withdraws Lawsuit Vs. Novo Nordisk

Law360, New York (October 28, 2004, 12:00 AM EDT) -- French drug maker Flamel Technologies SA has withdrawn its federal lawsuit against Danish rival Novo Nordisk over claims that Novo improperly used information from Flamel to file patent applications in the U.S.

The lawsuit was withdrawn “without prejudice” on Oct. 8, court documents show.

Flamel had sued Novo in U.S. District Court for the District of Delaware, claiming that its former partner had misused its technology for administering insulin to diabetics.

The French company claimed that since 1996 the two companies had signed four confidential agreements...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.